Understanding Orally Disintegrating Tablets

[Article Title]

Orally disintegrating tablets (ODTs) represent a breakthrough in pharmaceutical delivery, offering rapid dissolution in the mouth within 30 seconds and providing significant advantages for patient compliance, stability, and ease of administration. This whitepaper from Ascendia Pharma explores the critical excipients that make ODT formulations successful, comparing performance characteristics across leading commercial platforms including Ludiflash®, PEARLITOL® Flash, Prosolv® ODT G2, and others. Discover how co-processed excipients achieve the delicate balance between tablet hardness, disintegration time, and drug loading—and learn why proper storage and packaging are essential for maintaining ODT stability. Whether you're formulating new chemical entities or optimizing existing oral dosage forms, this guide provides valuable insights into ODT technology and practical considerations for successful product development.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.